Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing.

Cigna Corp's Express Scripts settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated ...

Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action "The fact is that in the unlikely event the ...

The settlement comes after years of meetings between NCPA and FTC staff, during which NCPA’s legal team educated government lawyers on the many egregious PBM practices that squash competition, reduce ...

Cigna and Express Scripts completed their $67 billion combination in December, forming a healthcare giant with $140 billion in revenue. Express Scripts Chief Technology Officer Phil Finucane is one of ...

FTC's July 2024 report makes unsubstantiated, false and biased claims about the PBM industry; fails to take into account the value that PBMs deliver to consumers and patients Information about Express ...

Amid increased scrutiny from policymakers, the pharmacy benefit manager (PBM) industry is now looking to strike back through legal channels. Express Scripts, one of the biggest PBMs in the U.S., ...

FTC's July 2024 report makes unsubstantiated, false and biased claims about the PBM industry; fails to take into account the value that PBMs deliver to consumers and patients ST. LOUIS, Sept. 17, 2024 ...

Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action ST. LOUIS, Sept. 20, 2024 /PRNewswire/ -- ...

Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry. Express Scripts is ...